{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:27:41Z","timestamp":1761560861520},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.yexcr.2003.10.034","type":"journal-article","created":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T10:58:32Z","timestamp":1071831512000},"page":"223-235","source":"Crossref","is-referenced-by-count":58,"title":["Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNF\u03b1"],"prefix":"10.1016","volume":"294","author":[{"given":"Emily J","family":"Foulstone","sequence":"first","affiliation":[]},{"given":"Camille","family":"Huser","sequence":"additional","affiliation":[]},{"given":"Anna L","family":"Crown","sequence":"additional","affiliation":[]},{"given":"Jeff M.P","family":"Holly","sequence":"additional","affiliation":[]},{"given":"Claire E.H","family":"Stewart","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2003.10.034_BIB1","unstructured":"K.C. Calman, Cancer cachexia. Br. J. Hosp. Med. 27 (1982) 28\u201329. 33\u201334."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJM199109053251005","article-title":"Catabolic illness","volume":"325","author":"Wilmore","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"DeWys","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB4","doi-asserted-by":"crossref","first-page":"15917","DOI":"10.1016\/S0021-9258(18)98496-6","article-title":"\u201cSpontaneous\u201d differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II","volume":"266","author":"Florini","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/physrev.1996.76.4.1005","article-title":"Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors","volume":"76","author":"Stewart","year":"1996","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB6","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1074\/jbc.271.32.19146","article-title":"Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells","volume":"271","author":"Kaliman","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0898-6568(00)00120-0","article-title":"Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase","volume":"12","author":"Li","year":"2000","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB8","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1210\/en.139.4.1794","article-title":"Mitogen-activated protein kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2","volume":"139","author":"Weyman","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2003.10.034_BIB9","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1074\/jbc.272.10.6653","article-title":"The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signalling pathways","volume":"272","author":"Coolican","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/en.143.2.511","article-title":"Early stimulation and late inhibition of extracellular signal-regulated kinase 1\/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation","volume":"143","author":"Adi","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2003.10.034_BIB11","first-page":"73","article-title":"IGF's, muscle growth, and myogenesis","volume":"3","author":"Florini","year":"1995","journal-title":"Diabetes Rev."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB12","doi-asserted-by":"crossref","first-page":"22305","DOI":"10.1016\/S0021-9258(18)41529-3","article-title":"A highly conserved insulin-like growth factor binding protein (IGFBP-5) is expressed during myoblast differentiation","volume":"268","author":"James","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1097-4652(199803)174:3<293::AID-JCP3>3.0.CO;2-J","article-title":"Role for cyclic adenosine monophosphate in modulating insulin-like growth factor binding protein secretion by muscle cells","volume":"174","author":"McCusker","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1677\/joe.0.1670403","article-title":"Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism","volume":"167","author":"Crown","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcp.10227","article-title":"Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts","volume":"195","author":"Foulstone","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumours secreting human TNF\/cachetin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2003.10.034_BIB17","first-page":"2554","article-title":"Persistence of the hypertriglyceridemic effect of tumour necrosis factor despite development of tachyphylaxis to its anorectic\/cachetic effects in rats","volume":"49","author":"Grunfeld","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB18","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1073\/pnas.88.9.3535","article-title":"Long term inhibition of tumour growth by tumour necrosis factor in the absence of cachexia or T-cell immunity","volume":"88","author":"Teng","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N","article-title":"Tumour necrosis factor \u03b1-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts","volume":"183","author":"Meadows","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcp.10017","article-title":"Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF\u03b1-induced apoptosis","volume":"189","author":"Foulstone","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB21","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1242\/jcs.112.17.2895","article-title":"In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle","volume":"112","author":"Cooper","year":"1999","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI118906","article-title":"Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects","volume":"98","author":"Henry","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI118504","article-title":"The expression of TNF alpha by human muscle. Relationship to insulin resistance","volume":"97","author":"Saghizadeh","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ajcn\/47.5.789","article-title":"Electrical impedance in assessing human body composition: the BIA method","volume":"47","author":"Khaled","year":"1988","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB25","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1073\/pnas.78.9.5623","article-title":"Isolation and characterisation of human muscle cells","volume":"78","author":"Blau","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB26","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/MCB.8.6.2295","article-title":"Tumour necrosis factor inhibits human myogenesis in vitro","volume":"8","author":"Miller","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB27","first-page":"1698","article-title":"Synergistic cytotoxic effect of interferon-gamma and tumour necrosis factor-alpha on cultured human muscle cells","volume":"22","author":"Kalovidouris","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00293401","article-title":"Initiation of satellite replication in bupivacine-induced myonecrosis","volume":"88","author":"Saito","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/diabetes.50.5.1102","article-title":"Effects of tumour necrosis factor-\u03b1 on insulin action in cultured human muscle cells","volume":"50","author":"Halse","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2003.10.034_BIB30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/dvdy.1227","article-title":"Insulin-like growth factor I stimulates myoblast expansion and myofiber development in the limb","volume":"223","author":"Mitchell","year":"2002","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB31","doi-asserted-by":"crossref","first-page":"12109","DOI":"10.1074\/jbc.270.20.12109","article-title":"Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice","volume":"270","author":"Coleman","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB32","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1101\/gad.7.12b.2609","article-title":"IGF-I is required for normal embryonic growth in mice","volume":"7","author":"Powell-Braxton","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB33","first-page":"29","article-title":"Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis","volume":"28","author":"Lemmey","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signalling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.onc.1200874","article-title":"Distinct signalling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras","volume":"14","author":"Weyman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2003.10.034_BIB36","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1074\/jbc.274.7.4341","article-title":"Stress-activated protein kinase-2\/p38 and a rapamycin sensitive pathway are required for C2C12 myogenesis","volume":"274","author":"Cuenda","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/0264-6021:3590001","article-title":"GSK-3 takes centre stage more than 20 years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB38","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1210\/me.12.12.1870","article-title":"Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signalling pathways during myogenic differentiation","volume":"12","author":"Sarbassov","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.yexcr.2003.10.034_BIB39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-I-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK-3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat. Cell. Biol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482703005834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482703005834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T15:36:48Z","timestamp":1623598608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482703005834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0014482703005834"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2003.10.034","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}